-
effectivehealthcare-admin.ahrq.gov/health-topics/diabetes-type-2?page=1
July 10, 2012 - Many people can manage their diabetes through healthy eating , physical activity, and blood glucose testing … Report November 9, 2009
Additional Patient Outcomes and Alternative Pathways in Evaluations of Testing
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pregnancy_hi_impact.pdf
January 01, 2012 - However, a negative result could help some women avoid more invasive
testing. … (San
Diego, CA; manufacturer of the testing platform), and stated intentions of filing a premarket … , citing the potential for miscarriages associated
with current invasive testing and the desire of … However, a health systems expert noted the opaque
nature of the genetic testing method, which could … Invasive prenatal testing
for aneuploidy.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/selecting-evidence-quiz.ppt
September 02, 2013 - Case reports are hypothesis generating rather than hypothesis testing. … Cohort and case-control studies are well suited for testing hypotheses of whether one intervention is … Cohort and case-control studies are well suited for testing hypotheses that one intervention is associated
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/selecting-evidence-quiz.ppt
September 02, 2013 - Case reports are hypothesis generating rather than hypothesis testing. … Cohort and case-control studies are well suited for testing hypotheses of whether one intervention is … Cohort and case-control studies are well suited for testing hypotheses that one intervention is associated
-
effectivehealthcare-admin.ahrq.gov/health-topics/diagnostic-imaging?page=0
October 25, 2024 - of Small Cell Lung Cancer
Systematic Review Archived March 29, 2016
Noninvasive Testing … for Multiple Sclerosis
Research Protocol Archived January 15, 2015
Noninvasive Testing
-
effectivehealthcare-admin.ahrq.gov/health-topics/diagnostic-imaging
October 25, 2024 - of Small Cell Lung Cancer
Systematic Review Archived March 29, 2016
Noninvasive Testing … for Multiple Sclerosis
Research Protocol Archived January 15, 2015
Noninvasive Testing
-
effectivehealthcare-admin.ahrq.gov/health-topics/chest-pain
November 14, 2017 - Depression: A Systematic Review
Systematic Review Archived March 29, 2016
Noninvasive Testing … Coronary Artery Disease
Research Protocol Archived January 15, 2015
Noninvasive Testing
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/cf_deliberativemethodswebinar_educatingsessionparticipants.pdf
May 18, 2012 - questioning by participants
– Problem – may assume adversarial positions
• Pretesting, cognitive testing
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests-update_executive.pdf
February 01, 2012 - Clinical testing of
high-spatial-resolution parametric contrast-enhanced MR imaging
of the breast.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/musculoskeletal-complaints-tests-children_research-protocol.pdf
September 29, 2010 - Protocol
Project Title: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-
Citrullinated Peptide Testing … No systematic reviews examining ANA for pediatric SLE or RF and
CCP testing for JIA were identified … of symptoms
KQ.3: What are the diagnostic performance characteristics of the ANA, RF, and CCP testing … Antinuclear antibody (ANA) testing. Pediatr Rev 2003;24:320-1.
4. Syed RH, Gilliam BE, Moore TL. … Anti-CCP antibody testing as a diagnostic and
prognostic tool in rheumatoid arthritis.
-
effectivehealthcare-admin.ahrq.gov/products/methods-guidance-tests-prognostic/methods
December 01, 2019 - exactly what it measures, how it is done, how clinical specimens are obtained, processed, and stored for testing … What is the applicable testing scenario? … Cost effectiveness: Do the improvements in patient outcomes justify the additional costs of testing and … Were the subjects somehow referred or selected for testing? What was the testing scenario?
-
effectivehealthcare-admin.ahrq.gov/products/test-performance-metrics/appendixes
December 01, 2019 - Sensitivity and Specificity
Sensitivity, also known as the true positive rate, is the probability of testing … Specificity, or true negative rate, is the probability of testing negative for non-diseased patients.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer_executive.pdf
February 01, 2008 - Largely because of widespread PSA
testing, the lifetime risk of being detected
with prostate cancer in … PSA testing detects
more tumors, at an earlier stage, with smaller volume
within each stage, and at an … Few enrolled men had prostate cancers
waiting detected by PSA testing. … Prostate cancers not
detected by PSA testing. … Only 5% of enrollees had prostate cancer detected by PSA
testing.
-
effectivehealthcare-admin.ahrq.gov/products/methods-guidance-tests-bias/methods
December 01, 2019 - don’t know status” are excluded and do not have their disease status verified (no reference standard testing … Relatives who are DECEASED are excluded from having any verification undertaken (no reference standard testing … Relatives who are UNABLE TO PARTICIPATE in interviews or further clinical testing are excluded from … having any verification method (no reference standard testing).
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-topics_methods.pdf
July 01, 2012 - medical test review are: to identify and
synthesize evidence to evaluate the impacts of alternative testing … The analytic framework was of limited value, as several
possible relevant testing strategies were not … The testing strategy in the lower portion of the decision
tree entails performing biopsy in all patients … Noninvasive carotid artery testing. A meta-
analytic review. … HER2 Testing to Manage Patients With
Breast Cancer or Other Solid Tumors.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-grading_methods.pdf
July 01, 2012 - standard
tools for grading evidence were designed for questions about treatment rather than
diagnostic testing … The degree of harms from false positives depends on the invasiveness of further testing or
treatment … versus not testing is a toss-up—where net
benefits are equivalent to net harms. … The impact of plausible unmeasured confounders may
be relevant to testing strategies that predict outcomes … Outcomes of Genetic Testing in Adults with a
History of Venous Thromboembolism.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_executive.pdf
March 01, 2012 - 1
Comparative Effectiveness Review
Number 50
Antinuclear Antibody, Rheumatoid Factor, and
Cyclic-Citrullinated Peptide Tests for Evaluating
Musculoskeletal Complaints in Children
Executive Summary
Background
Musculoskeletal (MSK) pain is common
in children and adolescents, with an
estimated prevalence rangin…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_surveillance.pdf
January 08, 2013 - CER #50:
Antinuclear Antibody, Rheumatoid Factor, and
Cyclic-Citrullinated Peptide Tests for Evaluating
Musculoskeletal Complaints in Children
Original release date:
March, 2012
Surveillance Report:
March, 2013
Key Findings:
- All conclusions from the original CER are up to date.
Summary Decisio…
-
effectivehealthcare-admin.ahrq.gov/products/cell-free-dna/draft-report
January 01, 2025 - studies (3 high risk-of-bias, 3 unclear risk of bias) reported prediagnostic performance estimated from testing
-
effectivehealthcare-admin.ahrq.gov/health-topics/emergency-medical-services?page=0
February 28, 2025 - the Emergency Department
Systematic Review Archived March 29, 2016
Noninvasive Testing … in Acute Care Settings
Research Protocol Archived January 15, 2015
Noninvasive Testing